阿昔洛韦预防肝移植受者巨细胞病毒感染和疾病的随机对照试验。 - Suppr

Suppr

超能文献

Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipients.

作者信息

Saliba F, Eyraud D, Samuel D, David M F, Arulnaden J L, Dussaix E, Mathieu D, Bismuth H

机构信息

Hepato-Biliary and Liver Transplant Unit, Hôpital Paul Brousse, Villejuif, France.

出版信息

Transplant Proc. 1993 Feb;25(1 Pt 2):1444-5.

PMID:8382876

Abstract

摘要

相似文献

Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipients.

Transplant Proc. 1993 Feb;25(1 Pt 2):1444-5.

Cytomegalovirus disease in liver transplant recipients: impact of acyclovir prophylaxis.

Transplant Proc. 1993 Jun;25(3):2282-3.

Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.

Transplantation. 2003 Jan 27;75(2):229-33. doi: 10.1097/01.TP.0000040601.60276.96.

[Open clinical trial with oral acyclovir for the prophylaxis of disease by Cytomegalovirus in low risk liver transplant recipients].

Enferm Infecc Microbiol Clin. 1999 Oct;17(8):382-5.

Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: a case-controlled study.

Transplant Proc. 1993 Feb;25(1 Pt 2):1431-3.

Viral prophylaxis in hepatic transplantation: preliminary report of a randomized trial of acyclovir and gancyclovir.

Transplant Proc. 1993 Apr;25(2):1935-7.

Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.

Transpl Infect Dis. 2000 Sep;2(3):112-7.

A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group.

Transplant Proc. 1994 Oct;26(5 Suppl 1):23-7.

Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.

Bone Marrow Transplant. 2002 Dec;30(12):945-51. doi: 10.1038/sj.bmt.1703770.

Prevention of cytomegalovirus disease in heart transplant recipients by prophylaxis with cytomegalovirus hyperimmune globulin plus oral acyclovir.

Transplant Proc. 1990 Oct;22(5):2322-3.

引用本文的文献

Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.

Cochrane Database Syst Rev. 2025 Jan 14;1(1):CD005133. doi: 10.1002/14651858.CD005133.pub4.

Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.

Cochrane Database Syst Rev. 2024 May 3;5(5):CD003774. doi: 10.1002/14651858.CD003774.pub5.

Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.

Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD005133. doi: 10.1002/14651858.CD005133.pub3.

Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients.

Paediatr Drugs. 2002;4(5):279-90. doi: 10.2165/00128072-200204050-00001.

New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Clin Microbiol Rev. 2000 Jan;13(1):83-121, table of contents. doi: 10.1128/CMR.13.1.83.

Infections in solid-organ transplant recipients.

Clin Microbiol Rev. 1997 Jan;10(1):86-124. doi: 10.1128/CMR.10.1.86.

Atypical oral presentation of herpes simplex virus infection in a patient after orthotopic liver transplantation.

Eur Arch Otorhinolaryngol. 1994;251(5):301-3. doi: 10.1007/BF00181890.

Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Drugs. 1994 Jan;47(1):153-205. doi: 10.2165/00003495-199447010-00009.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验